Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in high-risk elderly patients with COVID-19
NCT04416334Phase 3Completed
- Sponsor
- IDIVAL
- Start
- Aug 2020
- Primary completion
- Jun 2022
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in coronavirus disease 2019 (COVID-19), sponsored by IDIVAL. Started Aug 2020; status: completed.
02
Drugs
colchicine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04416334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04416334.